President and CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Patient PortalAdult ClinicPediatricsEye CareMake an AppointmentBillingInfo for Healthcare Professionals
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Professional Education

Joslin Diabetes Center is a leader in continuing education for healthcare professionals. Joslin's CME and CE activities promote the highest standards of care, drawing on up-to-date medical literature as well as cutting-edge research conducted at Joslin to provide current, relevant, and evidence-based findings from Joslin faculty and other experts. Our mission is to help providers offer their patients optimal management of diabetes and its related conditions, improved health outcomes, and enhanced quality of life.

Proven Success with Educational Outcomes


Joslin Diabetes Center has been at the forefront of measuring educational outcomes for our activities, based on the levels defined by Moore et al.1 We have been involved in several specific projects that measure the impact of our educational activities on clinician performance measures (Level 5) and patient outcomes measures (Level 6). Please click here to read about one of these initiatives entitled Targeting Type 2 Diabetes: Achieving Glycemic and Cardiometabolic Goals. This initiative was supported by educational grants from GlaxoSmithKline LLC and Merck Sharpe and Dohme Corp.

1 Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Health Prof. 2009;29(1):1-15.

Current Enduring Activities

Complementary Treatments to Enhance Insulin Efficacy: Theory and Strategies

Data supporting the use of GLP-1 receptor agonists in combination with basal insulin demonstrates the value of this treatment approach. This activity will provide learners with an update on data supporting combination therapy. It will empower diabetes specialty clinicians to more effectively identify people for whom this combination therapy would be indicated based on an assessment of their pathophysiology. Finally, it will highlight strategies to overcome barriers to injection therapy, and facilitate coordinated care with primary care providers.

This activity is supported by an educational grant from sanofi-aventis U.S. and is offered through our partner myCME. Expiration date: March 11, 2017.


Patient Case Study: An Obese Male With Very High A1C and High Motivation

Many clinicians delay initiation of needle-delivered medications as long as possible in T2DM, allowing patients to use lifestyle modifications plus metformin and eventually additional oral medications for an extended time, even when outcomes remain suboptimal. Not all patients benefit from this conservative approach, however. In the case presented here, the combination of an elevated A1C and a patient’s commitment to do whatever it takes to manage his diabetes demonstrate the value of expediting advancement to non-oral antidiabetes medications.

This activity is supported by an educational grant from Lilly USA, LLC and is offered through our partner myCME. Expiration date: June 16, 2016.


Biosimilar Insulins and Their Implications for Clinical Practice

Biosimilar medications are “highly similar” to an already FDA-approved biological product. One biosimilar is approved in the US, with more sure to follow in the near future, including a biosimilar insulin that is likely to have a significant impact on diabetes management. Although they will be responsible for ensuring safe and effective use of biosimilars, many clinicians are not familiar with the distinctions between biosimilars and generic drugs, including the different approval processes and regulatory issues surrounding these agents. These webcasts present the perspective of an endocrinologist versed in regulatory approval processes, and endocrinologist with expertise in insulin management, and a clinical pharmacist.

These activities are supported by an educational grant from Lilly USA, LLC and are offered through our partner myCME.

Link to Roundtable webcast.  Expiration date: May 5, 2016.

Link to Q&A webcast.  Expiration date: July 10, 2016.


SGLT2 Inhibitors in Type 2 Diabetes: Incorporating New Approaches Into Practice Through an Interdisciplinary Exploration

Type 2 diabetes mellitus (T2DM) remains undertreated in many patients, partly due to the progressive nature of the disease and the limitations of traditional therapies. Despite the plethora of available therapeutic options, adequate glycemic control is still often difficult to achieve, leading to serious complications. In this multidisciplinary Roundtable discussion, 4 key experts will provide their unique perspectives about SGLT2 inhibitors and their role in T2DM treatment. Two case studies allow the learner to apply knowledge to simulated patients.

These activities are supported by an educational grant from AstraZeneca LP and are offered through our partner myCME

Link to Roundtable webcast. Expiration date: June 29, 2016.

Link to Case 1: A Patient With Hypertension and Poorly Controlled Type 2 Diabetes.  Expiration date: June 29, 2016.

Link to Case 2: A Complex Patient With Type 2 Diabetes and Moderate CKD.  Expiration date: June 29, 2016.

Diabetes Screening and Management in Your Practice.pdf


Joslin at World Congress for CPD 2016

Joslin recently presented a session and a poster based on the performance improvement grant entitled Comparison of Methods for Assessing Clinical Performance Improvement in Primary Care.

View the poster here

Joslin Clinical Guidelines

To assist physicians and other healthcare professionals in managing the care of their patients with diabetes, Joslin offers approved clinical guidelines on a variety of topics including Adult Diabetes, Pharmacological Management of Type 2 Diabetes, and Continuous Glucose Monitors.

ACCME Awards Joslin CME Accreditation with Commendation

About Professional Education

ACCME Awards Joslin CME Accreditation with Commendation

Joslin Diabetes Center was awarded a six-year reaccreditation and the status of "Accreditation with Commendation" by the Accreditation Council for Continuing Medical Education (ACCME), the highest rating achievable by a provider of CME. Joslin was recognized for its exemplary performance in program planning, needs assessment, activity evaluation and evaluation of our overall educational program. Factors that contributed to this success are our consistently fair-balanced, evidence-based educational activities and our innovative educational outcomes measurement techniques.

Joslin Diabetes Center has helped revolutionize the diagnosis, treatment, and prevention of diabetes worldwide since its founding more than a century ago. Through its affiliation with Harvard Medical School and its staff of luminaries in their fields, Joslin has emerged as a leader in cutting-edge research and pioneering approaches to education and clinical care. Joslin's continuing education activities for physicians and other health professionals advance the highest standards of care, drawing on up-to-the-minute medical literature to provide current, relevant, and evidence-based findings from Joslin faculty and other experts.

Our mission is to empower healthcare providers to more effectively set the standards of diabetes care for their communities, helping to provide optimal management of all diabetes patients, improve healthcare outcomes, and enhance patient quality of life.

Continuing Medical Education (CME)

Joslin Diabetes Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Joslin’s programs are noted for their academic rigor, professional production, and aggressive audience generation efforts. Supported largely through educational grants, programs include live symposia and courses, satellite teleconferences, and Web-based and multimedia educational activities.

Continuing Education (CE)

Joslin develops educational programs for nurses, dietitians, pharmacists and others healthcare professionals. The acquisition of knowledge and skills needed to utilize diabetes treatments require repeated educational exposure to ensure that the necessary treatment changes are incorporated into daily practice. This education is important for all members of the diabetes team.

Educational Impact Assessment

Providing quality education is Joslin’s strength and priority. The ability to measure the effect that education has on the practices and processes of healthcare providers is an area in which Joslin has taken great strides. Through the implementation of the Educational Impact Assessment (EIA) tool, Joslin is able to quantify the effect an educational activity has in the real healthcare world. Contact us at (888) 567-5460 or by e-mail at for more information on EIA or any of our activities.

Page last updated: May 25, 2016


CME Activities

Click on an icon below to select the educational format that suits your schedule and preferred learning style.

SEARCH Joslin CME Activities

Receive credit for a Joslin self-study activity

If you have participated in a Joslin enduring material, go to Online Posttests to take the posttest and receive credit.

Page last updated: May 25, 2016


CE Activities

The Professional Education Department develops continuing education activities for nurses, dietitians, pharmacists, and other healthcare professionals.

REGISTER NOW: Transforming Diabetes Care
presented by the Johnson & Johnson Diabetes Institute, in collaboration with Joslin Diabetes Center

The diabetes professional education program goal is to transform diabetes care through a chronic care model approach. This is a unique opportunity for you to receive a customized curriculum delivered in a participant-centered learning environment. Over 5,000 healthcare providers, including doctors, nurse practitioners, diabetes educators and pharmacists have attended this program, and we are pleased to be bringing it to New England. Please click here for full details.

April 5-6, 2016   or
September 27-28, 2016
8am - 6pm

The agenda includes:
• Latest practice standards
• Patient communication
• Motivational interviewing
• Social support and depression
• Standards of care
• Decision points
• Interactive teaching techniques
• Pattern management
• The business of diabetes care
• Working with diverse populations
• Safe and effective use of diabetes technologies

Registration opens November 1, 2015
To register, go to and create an online profile

Page last updated: May 25, 2016


Stay informed!

Sign-up to be the first to know!

* Email
* First Name
* Last Name
* Degree
* Phone
* Business
* Address 1
* City
* State
* Zip
What would you like us to contact you about?

Other Comments:
* = Required Field


Page last updated: May 25, 2016